Candel Therapeutics (CADL) Stock
Candel Therapeutics (CADL) closed at $5.80 on Nov 16, 2026; its Tenet Score is 45 of 100 against 409 Healthcare peers.
Key stats
- Previous close
- $5.80
- Nov 16, 2026
- Market cap
- $454.6M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Dividend yield
- 0.00%
- reinvests all
- 52-week range
- 4.35 – 14.00
- low → high
- Tenet Score
- 45/100
- Mixed · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Candel Therapeutics Inc scores 45/100. Mixed. Strongest on financial health, quality is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 45 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=409Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
Pays no dividend. Every dollar of profit is reinvested into the business.
13F flows & insider trades land here.
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Geron Corp.GERN | 56 | $623.0M |
| Wave Life Sciences Inc.WVE | 54 | $617.3M |
| Pacific Biosciences of California, IncPACB | 40 | $613.3M |
| Climb Bio Inc.CLYM | 62 | $608.5M |
| Sana Biotechnology IncSANA | 34 | $605.3M |
| Evotec SEEVO | 51 | $561.8M |
| Capricor Therapeutics IncCAPR | 51 | $554.1M |
| Phathom Pharmaceuticals, Inc.PHAT | 33 | $492.6M |
| Avalo Therapeutics IncAVTX | 56 | $448.7M |
| Cerus CorpCERS | 33 | $400.9M |
Common questions
What sector and industry is Candel Therapeutics in?
Candel Therapeutics is in the Healthcare sector and the Drugs industry.
What is Candel Therapeutics' Tenet Score?
Candel Therapeutics' Tenet Score is 45 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




